The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation
November 02, 2017 18:54 ET
|
The Canadian Bioceutical Corporation
Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out
October 26, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced it has completed preparatory construction work and...
BCC Announces Initial US$10 Million Drawdown on Credit Facility
October 24, 2017 18:20 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market
October 13, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that, the Company, through its wholly-owned U.S....
BCC Reports Q1 Fiscal 2018 Results
September 28, 2017 21:35 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018,...
BCC Reports Q4 and Fiscal 2017 Results
September 08, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results for the fourth quarter and full...
BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia
August 22, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
Differentiation into high-growth market segment under new “Salus Bio-Pharma” brand JV will launch in Arizona & Massachusetts and, post closing of the acquisitions, in Nevada and Maryland. ...
BCC Completes Massachusetts Transaction
June 15, 2017 08:55 ET
|
The Canadian Bioceutical Corporation
TORONTO, Ontario, June 15, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that further to its press release of April 4,...
BCC Successfully Relocates Dispensary With First Week Sales Record
May 31, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, May 31, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) today announced that one of the two Health for Life dispensaries...
BCC Commences Trading on OTCQB
May 22, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, May 22, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTCQB:CBICF) announced that BCC common shares will commence trading in the...